- Home
- RLGT vs RCKT Comparison
RLGT vs RCKT Comparison
Compare RLGT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | RCKT |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.6M | 401.6M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLGT | RCKT |
|---|---|---|
| Price | $8.26 | $3.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $8.00 | ★ $29.73 |
| AVG Volume (30 Days) | 144.8K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $902,696,000.00 | N/A |
| Revenue This Year | $2.13 | N/A |
| Revenue Next Year | $5.18 | $64.28 |
| P/E Ratio | $36.67 | ★ N/A |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $5.78 | $2.19 |
| 52 Week High | $8.73 | $6.43 |
Technical Indicators
Market Signals| Indicator | RLGT | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 37.90 |
| Support Level | $5.86 | $3.02 |
| Resistance Level | $8.63 | $3.52 |
| Average True Range (ATR) | 0.35 | 0.23 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 65.14 | 22.25 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.